Spyre Therapeutics (SYRE) Plummets 14.3% Pre-Market Amid Market Caution
· gurufocus.com
On August 26, 2026, Spyre Therapeutics Inc (SYRE) saw a sharp pre-market decline of 14.3% as investors brace for Nvidia's earnings and key economic data release
On August 26, 2026, Spyre Therapeutics Inc SYRE saw a sharp pre-market decline of 14.3% as investors brace for Nvidia’s earnings and key economic data release...